Netanasvir

Star0

DB32272InvestigationalSmall molecule

Netanasvir: Overview.

Mechanism: Pharmacologically active on Nonstructural protein 5A
Curator reviewed
Formula / weight: C₅₁H₅₈N₈O₇ · 895.074 g/mol (avg)

Resolves to

Compound

UNII4Y7YD32BYYCAS2007900-70-9

Structure

InChIKeySXUUQUIMLYPBSV-IVSYMLMBSA-NSMILES

COC[C@H]1C[C@H](N(C1)C(=O)[C@H](NC(=O)OC)C1=CC=CC=C1)C1=NC=C(N1)C1=C2CCCC2=C(C=C1)C1=CC2=C(C=C1)C1=C(C=C2)N=C(N1)[C@@H]1CC[C@H](C)N1C(=O)[C@@H](NC(=O)OC)C(C)C

Targets

Q5L478NS5A

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Netanasvir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account